Invesco’s ADC Therapeutics ADCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$354K Sell
132,218
-486
-0.4% -$1.3K ﹤0.01% 3306
2025
Q1
$187K Buy
132,704
+98,335
+286% +$139K ﹤0.01% 3512
2024
Q4
$68.4K Buy
34,369
+1,700
+5% +$3.38K ﹤0.01% 3651
2024
Q3
$103K Sell
32,669
-290
-0.9% -$913 ﹤0.01% 3602
2024
Q2
$104K Buy
+32,959
New +$104K ﹤0.01% 3731
2022
Q1
Sell
-242,643
Closed -$4.9M 3963
2021
Q4
$4.9M Buy
242,643
+19,045
+9% +$385K ﹤0.01% 2412
2021
Q3
$6.07M Sell
223,598
-2,110
-0.9% -$57.3K ﹤0.01% 2278
2021
Q2
$5.5M Sell
225,708
-8,146
-3% -$198K ﹤0.01% 2383
2021
Q1
$5.71M Buy
233,854
+3,692
+2% +$90.1K ﹤0.01% 2308
2020
Q4
$7.37M Buy
230,162
+70,386
+44% +$2.25M ﹤0.01% 1963
2020
Q3
$5.27M Buy
+159,776
New +$5.27M ﹤0.01% 1979